Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Global Forecast to 2029

May 2024 | 591 pages | ID: PC4E5F81066EN
MarketsandMarkets

Abstracts

The preclinical imaging market is projected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR 5.9% during the forecast period. The market growth is mainly driven by factors such as increasing market demand for new drug development and noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, technological advancements in the field of molecular imaging, and development of low-cost & affordable preclinical imaging systems.

“Optical Imaging System accounted for the largest share of the market in the forecast period, by product type.”

Based on product, the preclinical imaging market is segmented into imaging systems, reagents, and software. The imaging systems is further segmented into optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic imaging, and magnetic particle imaging. The optical imaging segment captured the largest market share, primarily due to its extensive application in small animal imaging and new drug discovery projects. Several factors have contributed to the growing adoption of optical preclinical imaging. Technological advancements in molecular imaging have significantly enhanced the field, offering researchers more sophisticated and precise imaging capabilities.

“Oncology segment accounted for the largest share of the market in the forecast period, by application.”

Based on application, the preclinical imaging market is segmented into oncology, cardiology, neurology, infectious diseases, immunology and inflammation, and other applications. Among the preclinical imaging applications, oncology holds the largest share. This can be due to several factors such as preclinical imaging enables researchers to track tumor progression and treatment response in the same animal over time. This is particularly valuable in oncology for assessing the effectiveness of new drugs and therapies.

“The pharmaceutical and biotechnology companies segment accounted for the largest share of the market in the forecast period, by end user.”

Based on end user, the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic and research centers, imaging centers, and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest share during the forecast period. The demand for preclinical imaging in biotech companies has been steadily rising in recent years and is projected to continue growing. This increasing market demand in pharmaceutical and biotech companies is driven by the spread of emerging and re-emerging infectious diseases. Preclinical imaging is essential for gaining a better understanding of pathogens and for aiding the development of new therapeutics and vaccines.

“Asia Pacific to register the highest growth in the preclinical imaging market in the forecast period.”

The global preclinical imaging market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa. In 2023, Asia Pacific was expected to register the highest growth for preclinical imaging market in the forecast period. Factors such as lower research costs, less stringent regulatory guidelines, and increased government funding for the development of the research and development sector in these countries are making the region attractive for preclinical research studies. Consequently, the clinical research outsourcing (CRO) industry is thriving in emerging countries like China and India.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
• By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

The prominent players in this market are Bruker Corporation (US), Revvity, Inc. (US), MR Solutions (UK), Mediso Ltd. (UK), Trefoil Imaging (US), Fujifilm Visual Sonics (Canada), MILABS B.V. (Netherlands), Aspect Imaging Limited (US), Li-Cor Biosciences (US), ICONEUS (Paris), Advanced Molecular Vision (UK), IVIM Technology Corp. (South Korea), Cubresa, Inc. (Canada), Berthold Technologies GMBH & CO.KG (Germany), Sofie (US), Viewworks (Korea), AI4R (France), Kub Technologies (US), Medikor (US), and Miltenyi Biotech GmbH (Germany) . Players adopted organic as well as inorganic growth strategies such as new product launches, acquisitions, and expansions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the preclinical imaging market based on product type, application, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total brain computer interface market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

• Analysis of key drivers (technological advancements in the field of molecular imaging, increasing market demand for noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, and development of low-cost & affordable preclinical imaging systems), restraints (strict regulation, significant installation and operational cost ), opportunities (expansion in emerging markets, and increasing demand for non-invasive techniques) and challenge (Technological and procedural limitations associated with standalone preclinical imaging systems)
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the preclinical imaging market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of preclinical imaging solutions across regions.
• Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the preclinical imaging market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the preclinical imaging market.

Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS OF STUDY
1.4 MARKET SCOPE



  1.4.1 MARKET SEGMENTATION
FIGURE 1 PRECLINICAL IMAGING MARKET SEGMENTATION
  1.4.2 REGIONAL SCOPE
1.5 YEARS CONSIDERED
1.6 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.7 LIMITATIONS
1.8 STAKEHOLDERS
1.9 SUMMARY OF CHANGES
  1.9.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Primary sources
    2.1.2.2 Key data from primary sources
    2.1.2.3 Key industry insights
    2.1.2.4 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 PRECLINICAL IMAGING MARKET: COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 7 PRECLINICAL IMAGING MARKET: BOTTOM-UP APPROACH
FIGURE 8 PRECLINICAL IMAGING MARKET: TOP-DOWN APPROACH
2.3 GROWTH FORECAST
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PRECLINICAL IMAGING MARKET (2024–2029)
FIGURE 10 PRECLINICAL IMAGING MARKET: CAGR PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 MARKET FORECAST
TABLE 2 FACTOR ANALYSIS
2.7 RISK ANALYSIS
2.8 RECESSION IMPACT ANALYSIS
TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 4 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 5 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)

3 EXECUTIVE SUMMARY

FIGURE 12 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 13 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 PRECLINICAL IMAGING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 15 GEOGRAPHIC SNAPSHOT OF PRECLINICAL IMAGING MARKET

4 PREMIUM INSIGHTS

4.1 PRECLINICAL IMAGING MARKET OVERVIEW
FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING TO DRIVE MARKET
4.2 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 17 IMAGING SYSTEMS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PRECLINICAL IMAGING MARKET IN 2023
4.3 PRECLINICAL IMAGING SYSTEMS MARKET: REGIONAL MIX
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 PRECLINICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.5 PRECLINICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 PRECLINICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Technological advancements in molecular imaging
    5.2.1.2 Increasing demand for noninvasive small-animal imaging techniques
    5.2.1.3 Growing number of public-private initiatives and funding to support preclinical imaging
  5.2.2 RESTRAINTS
    5.2.2.1 Stringent regulations governing preclinical research
    5.2.2.2 Significant installation and operational costs associated with preclinical imaging modalities
  5.2.3 OPPORTUNITIES
    5.2.3.1 Emerging markets to offer growth opportunities
  5.2.4 CHALLENGES
    5.2.4.1 Technological and procedural limitations associated with standalone preclinical imaging systems
5.3 INDUSTRY TRENDS
  5.3.1 IMAGING BIOMARKERS
  5.3.2 MULTIMODAL IMAGING
5.4 TECHNOLOGY ANALYSIS
  5.4.1 KEY TECHNOLOGIES
    5.4.1.1 Photoacoustic tomography - MRI technology
    5.4.1.2 Multispectral optoacoustic tomography
  5.4.2 ADJACENT TECHNOLOGIES
    5.4.2.1 Contrast agents
    5.4.2.2 Magnetic particle imaging
  5.4.3 COMPLEMENTARY TECHNOLOGIES
    5.4.3.1 Molecular imaging
  5.4.4 PRICING ANALYSIS
    5.4.4.1 Average selling price trend, by region
TABLE 6 AVERAGE SELLING PRICE TREND OF PRECLINICAL IMAGING SYSTEMS, BY REGION
    5.4.4.2 Average selling price trend of key players, by product
TABLE 7 AVERAGE SELLING PRICE OF PRECLINICAL IMAGING PRODUCTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 22 PRECLINICAL IMAGING MARKET: VALUE CHAIN ANALYSIS:
5.6 ECOSYSTEM ANALYSIS
FIGURE 23 PRECLINICAL IMAGING MARKET: ECOSYSTEM ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 PRECLINICAL IMAGING MARKET: PORTER’S FIVE FORCES
FIGURE 24 PRECLINICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.7.1 BARGAINING POWER OF BUYERS
  5.7.2 BARGAINING POWER OF SUPPLIERS
  5.7.3 THREAT OF NEW ENTRANTS
  5.7.4 THREAT OF SUBSTITUTES
  5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY LANDSCAPE
  5.8.1 NORTH AMERICA
    5.8.1.1 US
TABLE 9 US FDA: CLASSIFICATION OF MEDICAL DEVICES
    5.8.1.2 Canada
TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  5.8.2 EUROPE
  5.8.3 ASIA PACIFIC
    5.8.3.1 Japan
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    5.8.3.2 China
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    5.8.3.3 India
  5.8.4 LATIN AMERICA
    5.8.4.1 Brazil
  5.8.5 MIDDLE EAST & AFRICA
    5.8.5.1 UAE
  5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PATENT ANALYSIS
  5.9.1 PATENT PUBLICATION TRENDS
  5.9.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS
FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS, 2013–2023
  5.9.3 MAJOR PATENTS
FIGURE 26 MAJOR PATENTS FOR PRECLINICAL IMAGING (2013–2023)
  5.9.4 LIST OF PATENTS/PATENT APPLICATIONS
5.10 TRADE ANALYSIS
  5.10.1 TRADE ANALYSIS FOR PRECLINICAL IMAGING SYSTEMS
FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 28 PRODUCT EXPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND)
5.11 CASE STUDY ANALYSIS
TABLE 16 CASE STUDY 1: PRECLINICAL DEVELOPMENT AND FIRST-IN-HUMAN STUDY OF 68GA-DOTA-MLN6907
TABLE 17 CASE STUDY 2: ACCELERATING PRECLINICAL ANALYSIS OF OCULAR DISEASES
TABLE 18 CASE STUDY 3: USAGE OF CRYO-FLUORESCENCE TOMOGRAPHY
5.12 KEY CONFERENCES & EVENTS, 2023–2024
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE
  5.13.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE
TABLE 21 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS
5.14 UNMET NEEDS ANALYSIS
TABLE 22 UNMET NEEDS IN PRECLINICAL IMAGING MARKET
  5.14.1 END-USER EXPECTATIONS
TABLE 23 END-USER EXPECTATIONS IN PRECLINICAL IMAGING MARKET
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.16 REIMBURSEMENT SCENARIO
TABLE 24 US: MEDICAL REIMBURSEMENT CPT CODES FOR PRECLINICAL IMAGING PROCEDURES (AS OF 2021)
5.17 BUSINESS MODEL ANALYSIS
5.18 INVESTMENT AND FUNDING SCENARIO
FIGURE 31 FUNDING OF PLAYERS IN PRECLINICAL IMAGING MARKET, 2023

6 PRECLINICAL IMAGING MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 25 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 26 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
6.2 IMAGING SYSTEMS
TABLE 27 PRECLINICAL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 28 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 29 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  6.2.1 OPTICAL IMAGING SYSTEMS
TABLE 30 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 31 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
    6.2.1.1 Bioluminescence imaging systems
      6.2.1.1.1 Advanced imaging techniques to propel adoption
TABLE 32 BIOLUMINESCENT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 33 BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.2.1.2 Fluorescence imaging systems
      6.2.1.2.1 Integration with other imaging modalities to support market growth
TABLE 34 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 35 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.2.1.3 Other optical imaging systems
TABLE 36 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 37 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.2 NUCLEAR IMAGING SYSTEMS
TABLE 38 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 39 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 40 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 41 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.2.2.1 Micro-PET imaging systems
TABLE 42 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 43 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 44 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 45 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.1.1 Standalone PET imaging systems
        6.2.2.1.1.1 Development of technologically advanced multimodality PET/CT imaging systems to limit market growth
TABLE 46 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 47 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.1.2 PET/CT imaging systems
        6.2.2.1.2.1 Expanding applications to aid market growth
TABLE 48 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 49 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.1.3 PET/MRI imaging systems
        6.2.2.1.3.1 Absence of ionizing radiations to aid market growth
TABLE 50 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 51 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.2.2.2 Micro-SPECT imaging systems
TABLE 52 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 53 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 54 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 55 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.2.1 SPECT/CT imaging systems
        6.2.2.2.1.1 Wide applications in oncology research to drive market
TABLE 56 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 57 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.2.2 SPECT/MRI imaging systems
        6.2.2.2.2.1 Enhanced sensitivity to aid market growth
TABLE 58 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 59 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.2.2.2.3 Standalone SPECT imaging systems
        6.2.2.2.3.1 Lower sensitivity and longer scan times to limit market growth
TABLE 60 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 61 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.2.2.3 Trimodality (SPECT/PET/CT) imaging systems
      6.2.2.3.1 High resolution of systems to drive adoption
TABLE 62 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 63 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.3 MICRO-MRI SYSTEMS
    6.2.3.1 Technological advancements to support market growth
TABLE 64 MICRO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 65 MIRCO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.4 MICRO-ULTRASOUND SYSTEMS
    6.2.4.1 Portable and cost-effective—key factors driving their adoption
TABLE 66 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 67 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.5 MICRO-CT SYSTEMS
    6.2.5.1 Technical advancements in X-ray sources and X-ray imaging arrays to support market growth
TABLE 68 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 69 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.6 PHOTOACOUSTIC IMAGING SYSTEMS
    6.2.6.1 Rising number of research studies for development of cancer therapeutics to drive market
TABLE 70 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 71 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.2.7 MAGNETIC PARTICLE IMAGING SYSTEMS
    6.2.7.1 Exceptional spatial resolution and sensitivity to aid market growth
TABLE 72 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 73 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3 REAGENTS
TABLE 74 PRECLINICAL IMAGING REAGENTS OFFERED BY KEY MARKET PLAYERS
TABLE 75 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 76 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  6.3.1 OPTICAL IMAGING REAGENTS
TABLE 77 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 78 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 79 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 80 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.1.1 Bioluminescent imaging reagents
TABLE 81 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 82 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 83 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 84 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.1.1 Luciferin
        6.3.1.1.1.1 Used in preclinical molecular imaging of gene expression in cell cultures, individual cells, and whole organisms
TABLE 85 LUCIFERIN MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 86 LUCIFERIN MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.1.2 Coelenterazine
        6.3.1.1.2.1 Lower bioavailability to limit market growth
TABLE 87 COELENTERAZINE MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 88 COELENTERAZINE MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.1.3 Furimazine
        6.3.1.1.3.1 Superior sensitivity and stability compared to traditional luciferase substrates enhance data accuracy
TABLE 89 FURIMAZINE MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 90 FURIMAZINE MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.1.2 Fluorescent imaging reagents
TABLE 91 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 92 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 93 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 94 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.2.1 Green fluorescent proteins
        6.3.1.2.1.1 Noninvasive visualization to drive market growth
TABLE 95 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 96 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.2.2 Red fluorescent proteins
        6.3.1.2.2.1 Growing use of RFPs in preclinical research to support market growth
TABLE 97 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 98 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.1.2.3 Infrared dyes
        6.3.1.2.3.1 Advancements in infrared imaging technology to propel market
TABLE 99 INFRARED DYES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 100 INFRARED DYES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.3.2 NUCLEAR IMAGING REAGENTS
TABLE 101 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 102 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 103 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 104 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.2.1 PET tracers
TABLE 105 PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 106 PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 107 PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 108 PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.1.1 Fluorine-18-based PET Tracers
        6.3.2.1.1.1 Most preferred PET tracer due to longer half-life
TABLE 109 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 110 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.1.2 Carbon-11-based PET Tracers
        6.3.2.1.2.1 Shorter half-life makes syntheses and commercial distribution difficult and complex
TABLE 111 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 112 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.1.3 Copper-64-based PET Tracers
        6.3.2.1.3.1 Low initial positron energy makes it suitable for imaging
TABLE 113 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 114 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.1.4 Other PET tracers
TABLE 115 OTHER PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 116 OTHER PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.2.2 SPECT probes
TABLE 117 SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 118 SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 119 SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 120 SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.2.1 Technetium-99m-based SPECT Probes
        6.3.2.2.1.1 Wide usage in various applications to support market growth
TABLE 121 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 122 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.2.2 Iodine-131-based SPECT Probes
        6.3.2.2.2.1 High risk of radiation hazards limits utilization in preclinical research studies
TABLE 123 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 124 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.2.3 Gallium-67-based SPECT Probes
        6.3.2.2.3.1 Widely used in nuclear imaging to study inflammation and chronic tumors
TABLE 125 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 126 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.2.4 Thallium-201-based SPECT Probes
        6.3.2.2.4.1 Longer half-life and low radiation dose to support market growth
TABLE 127 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 128 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
      6.3.2.2.5 Other SPECT probes
TABLE 129 OTHER SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 130 OTHER SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.3.3 MRI CONTRAST AGENTS
TABLE 131 MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 132 MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 133 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 134 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.3.1 Gadolinium-based contrast agents
      6.3.3.1.1 Rising number of research studies on neurological disorders to drive market
TABLE 135 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 136 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.3.2 Iron-based contrast agents
      6.3.3.2.1 Increasing number of research studies for development of novel cancer therapeutics to propel market
TABLE 137 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 138 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.3.3 Manganese-based contrast agents
      6.3.3.3.1 Toxicity of gadolinium-based contrast agents to drive demand
TABLE 139 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 140 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.3.4 ULTRASOUND CONTRAST AGENTS
    6.3.4.1 Advancements in ultrasound technology to support market growth
TABLE 141 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 142 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  6.3.5 CT CONTRAST AGENTS
TABLE 143 CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 144 CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 145 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 146 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.5.1 Iodine-based contrast agents
      6.3.5.1.1 Advancements in CT imaging technology to drive market
TABLE 147 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 148 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.5.2 Barium-based contrast agents
      6.3.5.2.1 Limited number of ongoing gastrointestinal research activities to hamper market growth
TABLE 149 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 150 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.5.3 Gold nanoparticles
      6.3.5.3.1 Advantages of gold nanoparticles over other CT contrast agents to increase demand
TABLE 151 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 152 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
    6.3.5.4 Gastrografin-based contrast agents
      6.3.5.4.1 Used for imaging of gastrointestinal tract
TABLE 153 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 154 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.4 SOFTWARE
  6.4.1 ADVANCES IN IMAGING TECHNOLOGIES NECESSITATE ADVANCED SOFTWARE FOR DATA HANDLING AND ANALYSIS
TABLE 155 PRECLINICAL IMAGING SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 156 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 157 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION)

7 PRECLINICAL IMAGING MARKET, BY APPLICATION

7.1 INTRODUCTION
TABLE 158 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 159 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
7.2 ONCOLOGY
  7.2.1 GROWING FOCUS ON DEVELOPMENT OF ONCOLOGY THERAPEUTICS TO DRIVE MARKET
TABLE 160 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 161 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2029 (USD MILLION)
7.3 CARDIOLOGY
  7.3.1 INCREASED FOCUS ON TARGETED TREATMENTS FOR CVD TO PROPEL MARKET
TABLE 162 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 163 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2029 (USD MILLION)
7.4 NEUROLOGY
  7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO SUPPORT MARKET GROWTH
TABLE 164 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 165 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2029 (USD MILLION)
7.5 INFECTIOUS DISEASES
  7.5.1 RISING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
TABLE 166 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 167 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
7.6 IMMUNOLOGY & INFLAMMATION
  7.6.1 ADVANCEMENTS IN IMMUNOTHERAPY RESEARCH TO PROPEL MARKET
TABLE 168 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 169 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2023–2029 (USD MILLION)
7.7 OTHER APPLICATIONS
TABLE 170 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 171 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)

8 PRECLINICAL IMAGING MARKET, BY END USER

8.1 INTRODUCTION
TABLE 172 PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 173 PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  8.2.1 MAJOR END USERS DUE TO EXTENSIVE INVOLVEMENT IN DRUG DISCOVERY AND DEVELOPMENT PROCESSES
TABLE 174 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 175 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2029 (USD MILLION)
8.3 ACADEMIC & RESEARCH CENTERS
  8.3.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
TABLE 176 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 177 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
8.4 IMAGING CENTERS
  8.4.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
TABLE 178 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 179 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
8.5 OTHER END USERS
TABLE 180 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 181 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION)

9 PRECLINICAL IMAGING MARKET, BY REGION

9.1 INTRODUCTION
TABLE 182 PRECLINICAL IMAGING MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 183 PRECLINICAL IMAGING MARKET, BY REGION, 2023–2029 (USD MILLION)
9.2 NORTH AMERICA
  9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 32 NORTH AMERICA: PRECLINICAL IMAGING MARKET SNAPSHOT
TABLE 184 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 185 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 186 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 187 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 188 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 189 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 190 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 191 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 192 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 193 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 194 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018–2022 (USD MILLION)
TABLE 195 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023–2029 (USD MILLION)
TABLE 196 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 197 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 198 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 199 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 201 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 202 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 203 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 204 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 205 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 207 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 209 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 210 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 211 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 212 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 213 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 214 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 215 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 216 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 217 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 218 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 219 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.2.2 US
    9.2.2.1 Rapid adoption of technologically advanced imaging systems to drive growth
TABLE 220 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 221 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 222 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 223 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 224 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 225 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 226 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 227 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 228 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 229 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 230 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 231 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 232 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 233 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 234 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 235 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 236 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 237 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 238 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 239 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 240 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 241 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 242 US: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 243 US: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 244 US: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 245 US: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 246 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 247 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 248 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 249 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 250 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 251 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 252 US: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 253 US: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.2.3 CANADA
    9.2.3.1 Growth in stem cell research activities to support market growth
TABLE 254 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 255 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 256 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 257 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 258 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 259 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 260 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 261 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 262 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 263 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 264 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 265 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 266 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 267 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 268 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 269 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 270 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 271 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 272 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 273 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 274 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 275 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 276 CANADA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 277 CANADA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 278 CANADA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 279 CANADA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 280 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 281 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 282 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 283 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 284 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 285 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 286 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 287 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
9.3 EUROPE
  9.3.1 EUROPE: RECESSION IMPACT
TABLE 288 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 289 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 290 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 291 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 292 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 293 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 294 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 295 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 296 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 297 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 298 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 299 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 300 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 301 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 302 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 303 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 304 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 305 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 306 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 307 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 308 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 309 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 310 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 311 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 312 EUROPE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 313 EUROPE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 314 EUROPE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 315 EUROPE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 316 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 317 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 318 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 319 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 320 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 321 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 322 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 323 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.2 GERMANY
    9.3.2.1 Growth in biotechnology industry to propel market
TABLE 324 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 325 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 326 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 327 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 328 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 329 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 330 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 331 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 332 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 333 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 334 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 335 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 336 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 337 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 338 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 339 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 340 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 341 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 342 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 343 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 344 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 345 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 346 GERMANY: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 347 GERMANY: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 348 GERMANY: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 349 GERMANY: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 350 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 351 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 352 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 353 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 354 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 355 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 356 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 357 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.3 UK
    9.3.3.1 Increasing focus on cancer research to drive market
TABLE 358 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 359 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 360 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 361 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 362 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 363 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 364 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 365 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 366 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 367 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 368 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 369 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 370 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 371 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 372 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 373 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 374 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 375 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 376 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 377 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 378 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 379 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 380 UK: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 381 UK: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 382 UK: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 383 UK: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 384 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 385 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 386 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 387 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 388 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 389 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 390 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 391 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.4 FRANCE
    9.3.4.1 Increased investments in proteomics and genomics to fuel market growth
TABLE 392 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 393 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 394 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 395 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 396 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 397 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 398 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 399 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 400 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 401 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 402 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 403 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 404 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 405 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 406 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 407 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 408 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 409 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 410 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 411 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 412 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 413 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 414 FRANCE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 415 FRANCE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 416 FRANCE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 417 FRANCE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 418 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 419 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 420 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 421 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 422 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 423 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 424 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 425 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.5 ITALY
    9.3.5.1 Growth in biotechnology and pharmaceutical industries to drive market
TABLE 426 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 427 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 428 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 429 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 430 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 431 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 432 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 433 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 434 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 435 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 436 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 437 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 438 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 439 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 440 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 441 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 442 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 443 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 444 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 445 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 446 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 447 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 448 ITALY: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 449 ITALY: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 450 ITALY: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 451 ITALY: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 452 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 453 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 454 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 455 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 456 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 457 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 458 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 459 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.6 SPAIN
    9.3.6.1 Extensive R&D pipeline to support market growth
TABLE 460 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 461 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 462 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 463 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 464 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 465 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 466 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 467 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 468 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 469 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 470 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 471 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 472 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 473 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 474 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 475 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 476 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 477 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 478 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 479 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 480 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 481 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 482 SPAIN: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 483 SPAIN: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 484 SPAIN: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 485 SPAIN: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 486 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 487 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 488 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 489 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 490 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 491 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 492 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 493 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
  9.3.7 REST OF EUROPE
TABLE 494 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 495 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 496 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 497 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 498 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 499 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 500 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 501 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 502 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018–2022 (USD MILLION)
TABLE 503 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023–2029 (USD MILLION)
TABLE 504 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 505 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 506 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 507 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 508 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 509 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 510 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 511 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 512 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 513 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 514 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 515 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 516 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 517 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 518 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 519 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 520 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 521 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 522 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 523 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 524 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 525 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 526 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 527 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
9.4 ASIA PACIFIC
  9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 ASIA PACIFIC: PRECLINICAL IMAGING MARKET SNAPSHOT
TABLE 528 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 529 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 530 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
TABLE 531 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 532 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 533 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 534 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 535 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 536 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 537 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 538 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 539 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 540 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 541 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 542 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 543 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 544 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 545 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 546 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 547 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 548 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 549 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 550 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 551 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 552 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 553 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 554 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 555 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 556 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 557 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 558 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 559 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 560 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 561 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 562 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 563 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)

About

The report “Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging).

This report studies the global preclinical imaging market over the forecast period of 2014 to 2019. The market is expected to reach $797 million by 2019, at CAGR of 6.0% from 2014 to 2019.

Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada) are the key players operating in the global preclinical imaging systems and reagents market.

A number of factors such as technological advancements in molecular imaging modalities, rising adoption of multi-modality imaging systems in preclinical research studies, and growing acceptance of preclinical imaging in drug discovery and development processes are fuelling the demand of preclinical imaging systems and reagents. On the other hand, declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global preclinical imaging market.

As of 2014, North America holds the largest share of the global preclinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2014 to 2019. A number of factors, including rising R&D activities by big pharma and biotech companies in developing nations, increased government funding for development of pharmaceutical industry, and growing number of CROs in emerging markets are stimulating the growth of the preclinical imaging market in the Asia-Pacific region. However, challenges associated with the application of radioisotopes, such as short half-life of PET radioisotopes and high cost involved in the generation of these isotopes, restricts the demand for micro-PET systems in developing Asian countries.